Print Page

其 他 安 全 警 示
 
European Union: EMA confirms measures to minimise the risk of serious side effects with medicines containing pseudoephedrine (English only)
 
 
 
附件:
  1. European Union: EMA confirms measures to minimise the risk of serious side effects with medicines containing pseudoephedrine (English only)  
Related Information:
Singapore: Pseudoephedrine and the rare risk of posterior reversible encephalopa... 上載於 2024-04-29
Singapore: Zyrtec-D: Risks of posterior reversible encephalopathy syndrome and r... 上載於 2024-03-18
The United Kingdom: Pseudoephedrine: very rare risk of posterior reversible ence... 上載於 2024-02-21
PRAC recommends measures to minimise the risk of serious side effects with medic... 上載於 2023-12-04
European Union: PRAC recommends measures to minimise the risk of serious side ef... 上載於 2023-12-02
The United Kingdom: MHRA safety review of medicines containing pseudoephedrine (... 上載於 2023-02-27
European Union: PRAC starts safety review of pseudoephedrine-containing medicine... 上載於 2023-02-11
 
back